Drug
AC-1202
AC-1202 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
terminated125%
withdrawn125%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_1
Tricaprilin Liquid Formulation PK Study
NCT05028114
withdrawnphase_1
Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides
NCT03635879
completedphase_1
Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
NCT03063645
completedphase_1
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
NCT02833012
Clinical Trials (4)
Showing 4 of 4 trials
NCT05028114Phase 1
Tricaprilin Liquid Formulation PK Study
NCT03635879Phase 1
Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides
NCT03063645Phase 1
Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
NCT02833012Phase 1
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4